Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Invested Capital (2018 - 2026)

Health Catalyst filings provide 9 years of Invested Capital readings, the most recent being $291.5 million for Q1 2026.

  • On a quarterly basis, Invested Capital fell 61.63% to $291.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $291.5 million, a 61.63% decrease, with the full-year FY2025 number at $399.0 million, down 46.62% from a year prior.
  • Invested Capital hit $291.5 million in Q1 2026 for Health Catalyst, down from $399.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $759.7 million in Q1 2025 to a low of $291.5 million in Q1 2026.
  • Median Invested Capital over the past 5 years was $610.0 million (2023), compared with a mean of $588.3 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 60.27% in 2022 and later crashed 61.63% in 2026.
  • Health Catalyst's Invested Capital stood at $425.0 million in 2022, then surged by 39.99% to $595.0 million in 2023, then rose by 25.65% to $747.6 million in 2024, then tumbled by 46.62% to $399.0 million in 2025, then fell by 26.95% to $291.5 million in 2026.
  • The last three reported values for Invested Capital were $291.5 million (Q1 2026), $399.0 million (Q4 2025), and $485.1 million (Q3 2025) per Business Quant data.